| scholarly article | Q13442814 |
| P2093 | author name string | John O Cisar | |
| Dennis J Kopecko | |||
| Donald H Burr | |||
| De-Qi Xu | |||
| Nicholas Ambulos Jr | |||
| P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers | Q28131744 | ||
| Pseudomonas aeruginosa AlgG is a polymer level alginate C5-mannuronan epimerase | Q28492682 | ||
| Functional conservation of the polysaccharide biosynthetic protein WbpM and its homologues in Pseudomonas aeruginosa and other medically significant bacteria | Q28492875 | ||
| Functional analysis of genes responsible for the synthesis of the B-band O antigen of Pseudomonas aeruginosa serotype O6 lipopolysaccharide | Q28493117 | ||
| Food-related illness and death in the United States | Q29615940 | ||
| WbpO, a UDP-N-acetyl-D-galactosamine dehydrogenase from Pseudomonas aeruginosa serotype O6. | Q31423575 | ||
| Structure, assembly and regulation of expression of capsules in Escherichia coli | Q33592585 | ||
| Comparison of O-antigen gene clusters of Escherichia coli (Shigella) sonnei and Plesiomonas shigelloides O17: sonnei gained its current plasmid-borne O-antigen genes from P. shigelloides in a recent event | Q33593386 | ||
| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies | Q33749510 | ||
| Role of the Escherichia coli O157:H7 O side chain in adherence and analysis of an rfb locus. | Q35529931 | ||
| Complete sequence of IS629 | Q35835904 | ||
| Complete nucleotide sequence and molecular characterization of ViaB region encoding Vi antigen in Salmonella typhi | Q36103161 | ||
| Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels | Q36327033 | ||
| A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum | Q36389327 | ||
| Shigella sonnei plasmids: evidence that a large plasmid is necessary for virulence. | Q36428530 | ||
| Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain | Q36431701 | ||
| A pSC101-derived plasmid which shows no sequence homology to other commonly used cloning vectors | Q36587315 | ||
| Cloning and expression of an Azotobacter vinelandii mannuronan C-5-epimerase gene | Q36750715 | ||
| Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei | Q36985066 | ||
| A putative pathway for perosamine biosynthesis is the first function encoded within the rfb region of Vibrio cholerae O1. | Q38288526 | ||
| Escherichia coli clone Sonnei (Shigella sonnei) had a chromosomal O-antigen gene cluster prior to gaining its current plasmid-borne O-antigen genes. | Q39566331 | ||
| Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model | Q39573053 | ||
| DNA sequence of IS91 and identification of the transposase gene | Q39936049 | ||
| Molecular analysis of variant plasmid forms of a bivalent Salmonella typhi-Shigella sonnei vaccine strain | Q40210819 | ||
| Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen. | Q40825801 | ||
| Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine | Q40897058 | ||
| Construction and characterization of new cloning vehicles III. Derivatives of plasmid pBR322 carrying unique Eco RI sites for selection of Eco RI generated recombinant DNA molecules | Q40966171 | ||
| Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen | Q41172531 | ||
| A family of gram-negative bacterial outer membrane factors that function in the export of proteins, carbohydrates, drugs and heavy metals from gram-negative bacteria | Q41642150 | ||
| Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide | Q42594524 | ||
| The complete DNA sequence of the O antigen gene region of Plesiomonas shigelloides serotype O17 which is identical to Shigella sonnei form I antigen | Q42625297 | ||
| The assembly system for the lipopolysaccharide R2 core-type of Escherichia coli is a hybrid of those found in Escherichia coli K-12 and Salmonella enterica. Structure and function of the R2 WaaK and WaaL homologs. | Q42675440 | ||
| Genetic analysis of Shigella sonnei form I antigen: identification of a novel IS630 as an essential element for the form I antigen expression | Q42686390 | ||
| Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung | Q48043443 | ||
| Expression of the O antigen gene cluster is regulated by RfaH through the JUMPstart sequence | Q50129700 | ||
| Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains | Q50169617 | ||
| Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine | Q50201269 | ||
| Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. | Q50464343 | ||
| Immunity in Shigellosis. I. Response of Man to Attenuated Strains of Shigella | Q54040438 | ||
| Molecular cloning and characterization of form I antigen genes of Shigella sonnei | Q54699055 | ||
| Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection | Q69156182 | ||
| A small cosmid for efficient cloning of large DNA fragments | Q72886903 | ||
| FlaA1, a new bifunctional UDP-GlcNAc C6 Dehydratase/ C4 reductase from Helicobacter pylori | Q74212843 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polysaccharide | Q134219 |
| Shigella sonnei | Q6382438 | ||
| P304 | page(s) | 4414-4423 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector | |
| P478 | volume | 70 |
| Q40045688 | A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection |
| Q49925237 | A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection |
| Q41730915 | A novel multiplex PCR for the simultaneous detection of Salmonella enterica and Shigella species |
| Q35202321 | An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei |
| Q37145004 | Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge |
| Q46404116 | Biochemical characterization of the Campylobacter jejuni Cj1294, a novel UDP-4-keto-6-deoxy-GlcNAc aminotransferase that generates UDP-4-amino-4,6-dideoxy-GalNAc |
| Q42602074 | Characterization of E. coli O24 and O56 O antigen gene clusters reveals a complex evolutionary history of the O24 gene cluster |
| Q36844719 | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road |
| Q33736542 | Comparative Genomic and Phylogenetic Analysis of a Shiga Toxin Producing Shigella sonnei (STSS) Strain. |
| Q36101210 | Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries |
| Q40444589 | Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection |
| Q36145803 | Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery |
| Q37116180 | Genome Sequence of Salmonella enterica Serovar Typhi Oral Vaccine Strain Ty21a |
| Q38789796 | Haemophilus parainfluenzae expresses diverse lipopolysaccharide O-antigens using ABC transporter and Wzy polymerase-dependent mechanisms |
| Q34300870 | Identification of the Vibrio vulnificus wbpP gene and evaluation of its role in virulence |
| Q37309260 | Lipopolysaccharide: a tool and target in enterobacterial vaccine development |
| Q38452524 | Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications |
| Q42910252 | Predicted functions and linkage specificities of the products of the Streptococcus pneumoniae capsular biosynthetic loci |
| Q40114957 | Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection |
| Q92058286 | Shigella sonnei O-Antigen Inhibits Internalization, Vacuole Escape, and Inflammasome Activation |
| Q47093813 | Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a. |
| Q40087889 | Stable expression of Shigella dysenteriae serotype 1 O-antigen genes integrated into the chromosome of live Salmonella oral vaccine vector Ty21a |
| Q42181717 | Structural characterization of ISCR8, ISCR22, and ISCR23, subgroups of IS91-like insertion elements |
| Q37142131 | Structure and genetics of Shigella O antigens |
| Q35757935 | The influence of riboflavin and nicotinic acid on Shigella sonnei colony conversion |
| Q41475755 | Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice |
Search more.